Stockscreener 앱 받기
2.26
5.83%
-0.14
시간 외 거래:
2.34
0.08
+3.54%
전일 마감가:
$2.40
열려 있는:
$2.39
하루 거래량:
64,285
Relative Volume:
0.24
시가총액:
$126.34M
수익:
-
순이익/손실:
$-21.38M
주가수익비율:
-5.7949
EPS:
-0.39
순현금흐름:
$-25.19M
1주 성능:
-16.30%
1개월 성능:
-5.83%
6개월 성능:
+93.28%
1년 성능:
+94.83%
1일 변동 폭
$2.26
$2.4449
1주일 범위
$2.26
$2.83
52주 변동 폭
$0.51
$3.28
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
CNTB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.26 | 134.17M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | Lake Street | Buy |
| 2025-10-31 | 개시 | BTIG Research | Buy |
| 2025-06-12 | 개시 | H.C. Wainwright | Buy |
| 2024-03-04 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-04-13 | 개시 | Piper Sandler | Overweight |
| 2021-04-13 | 개시 | SVB Leerink | Outperform |
모두보기
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Newport Daily News
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Announces Board Resignation - TradingView — Track All Markets
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Connect Biopharma Hldgs (CNTB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Hillsdale Daily News
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
CASI Pharmaceuticals Announces Changes in Board Governance - Investing News Network
Shareholder Panacea Innovation Ltd Files To Sell 2,000,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Taking on analysts’ expectations and winning: Connect Biopharma Holdings Ltd (CNTB) - Setenews
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Shareholder Zheng-Wu Family Trust Files To Sell 650,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Connect Biopharma Holdings Limited (CNTB) -11.98% in Normal Trading: Shares Decline Amidst Recent Developments - Stocks Telegraph
CASI Pharmaceuticals (NASDAQ: CASI) appoints James Huang Non-Executive Chairman - Stock Titan
Owner BioFortune Inc Files To Sell 500,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
HC Wainwright Issues Pessimistic Estimate for CNTB Earnings - Defense World
Connect Biopharma Reports Significant Loss Amid Development Efforts - TipRanks
Perhaps timely catching Lazydays Holdings Inc (GORV) would be a good idea - setenews.com
The time has not yet come to remove your chips from the table: Connect Biopharma Holdings Ltd (CNTB) - Setenews
FY2025 EPS Forecast for Connect Biopharma Lowered by Analyst - MarketBeat
Connect Biopharma’s (CNTB) “Buy” Rating Reiterated at BTIG Research - Defense World
Araptus launches affordable Black Friday web package for small businesses at $900 setup + $100/month - St. Cloud Times
Connect Biopharma's (CNTB) Buy Rating Reiterated at BTIG Research - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
BTIG Reiterates Buy Rating for CNTB with $10 Price Target | CNTB Stock News - GuruFocus
Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView
[10-Q] Connect Biopharma Holdings Ltd Quarterly Earnings Report | CNTB SEC FilingForm 10-Q - Stock Titan
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):